Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reflects a mixed outlook. Positive revenue growth of 25% and a slight improvement in net loss are offset by increased R&D and G&A expenses. Regulatory hurdles, market conditions, and supply chain risks present uncertainties. The absence of shareholder return discussions and unclear management responses in the Q&A add to the neutral sentiment. The strategic initiatives are promising but hinge on future regulatory approvals and market conditions. Overall, the stock is likely to remain stable in the short term.
Revenue Scholar Rock reported revenue of $15.2 million for Q1 2026, representing a 25% increase year-over-year. This growth was primarily driven by increased collaboration revenue from partnerships.
Research and Development (R&D) Expenses R&D expenses were $22.8 million, up 10% compared to the same period last year. The increase was attributed to higher costs associated with advancing clinical trials and expanding the R&D team.
General and Administrative (G&A) Expenses G&A expenses totaled $8.5 million, reflecting a 5% increase year-over-year. This rise was due to higher personnel costs and investments in infrastructure to support growth.
Net Loss The company reported a net loss of $16.1 million, which is a slight improvement from the $17.3 million net loss in Q1 2025. The improvement was due to higher revenue partially offsetting increased expenses.
The selected topic was not discussed during the call.
Regulatory Hurdles: Potential delays in regulatory approvals for new therapies could impact the company's ability to bring products to market on time.
Market Conditions: Unfavorable market conditions could affect the company's financial performance and ability to compete effectively.
Supply Chain Disruptions: Disruptions in the supply chain could lead to delays in product availability and increased costs.
Strategic Execution Risks: Challenges in executing strategic plans could hinder the company's growth and operational efficiency.
Introductory Remarks: David Hallal, Chairman and CEO, will provide introductory remarks and a business update.
R&D Progress: Akshay Vaishnaw, President of R&D, will review R&D progress.
Commercial Readiness: Keith Woods, COO, will provide an update on commercial readiness activities.
Financial Update: Vikas Sinha, CFO, will provide a financial update.
The selected topic was not discussed during the call.
The earnings call reflects a mixed outlook. Positive revenue growth of 25% and a slight improvement in net loss are offset by increased R&D and G&A expenses. Regulatory hurdles, market conditions, and supply chain risks present uncertainties. The absence of shareholder return discussions and unclear management responses in the Q&A add to the neutral sentiment. The strategic initiatives are promising but hinge on future regulatory approvals and market conditions. Overall, the stock is likely to remain stable in the short term.
The earnings call summary and Q&A reveal a mixed sentiment. The company's financial position is stable with cash reserves, but there is no immediate positive catalyst like a new partnership or record high revenue. The focus is on long-term product development and regulatory approvals, with some uncertainties in timelines and pricing details. The Q&A section shows a cautious yet optimistic management outlook but lacks concrete near-term financial guidance. The market reaction is likely to be neutral, as the stock price may not significantly change without immediate impactful news.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.